Carlsmed Inc (CARL)

$12.56 -0.50 (-3.83%)
Market Cap 347.31M
Revenue (ttm) 27.17M
Net Income (ttm) -24.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89.29%
Debt to Equity Ratio 0.14
Volume 178,400
Avg Vol 89,670
Day's Range N/A - N/A
Shares Out 26.59M
Stochastic %K 74%
Beta N/A
Analysts Strong Sell
Price Target $19.40

Company Profile

Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is...

Industry: Health Information Services
Sector: Healthcare
Phone: 760 766 1923
Address:
1800 Aston Avenue, Suite 100, Carlsbad, United States
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 10:23 PM
$CARL Q4 '25 Earnings Results & Recap Carlsmed anticipates gross margin to remain constant short-term and modestly increase medium-to-long-term due to efficiencies. The company also expects broader commercialization of its aprevo cervical platform in 2026.
0 · Reply
OnyxPredator
OnyxPredator Feb. 23 at 1:29 PM
$LFS $LONA $CARL $PAAS .’x
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 22 at 9:28 PM
$CARL Current Stock Price: $12.79
0 · Reply
SentimentSwings
SentimentSwings Feb. 18 at 3:36 PM
$CARL Carlyle Secured Lending is a BDC focused on first-lien loans. Yield is attractive but tied to credit health. NAV stability is the key performance metric.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 12 at 4:20 PM
$CARL RSI: 25.37, MACD: -0.4265 Vol: 0.76, MA20: 12.44, MA50: 12.90 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
RaymondNorman877
RaymondNorman877 Feb. 11 at 2:06 PM
$CARL Carl or unknown micro-cap; ticker ambiguous, likely represents a shell or dormant issuer with extreme liquidity constraints.
0 · Reply
jimbecker
jimbecker Jan. 27 at 5:29 PM
$CARL Regained the 50 Day Simple Moving Average on average volume. Sales increasing as well as institutional buying.
0 · Reply
Jesterberg69
Jesterberg69 Jan. 23 at 12:58 AM
$CARL CARL turns me on
0 · Reply
Yokozuna911
Yokozuna911 Jan. 22 at 3:49 PM
$CARL IPO stock lock-up period expired on Monday, January 19, 2026.
0 · Reply
Orveniuygv
Orveniuygv Jan. 13 at 6:38 PM
$CARL thin float microcap, quiet accumulation, watch for volume ignition and fast price discovery
0 · Reply
Latest News on CARL
Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript

Feb 25, 2026, 7:47 PM EST - 10 hours ago

Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 25, 2026, 4:01 PM EST - 14 hours ago

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

Feb 23, 2026, 4:01 PM EST - 2 days ago

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

Feb 18, 2026, 4:05 PM EST - 7 days ago

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Feb 11, 2026, 4:01 PM EST - 14 days ago

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure

Feb 10, 2026, 9:00 AM EST - 15 days ago

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure

Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

Jan 12, 2026, 8:05 AM EST - 6 weeks ago

Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal

Jan 6, 2026, 4:05 PM EST - 7 weeks ago

Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal

Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference

Dec 16, 2025, 4:01 PM EST - 2 months ago

Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference

Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting

Dec 3, 2025, 7:00 AM EST - 3 months ago

Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 4:01 PM EST - 3 months ago

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference

Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance

Nov 6, 2025, 4:01 PM EST - 3 months ago

Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance

Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 23, 2025, 4:01 PM EDT - 4 months ago

Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025

Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary

Sep 29, 2025, 9:00 AM EDT - 5 months ago

Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary

Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index

Sep 22, 2025, 9:00 AM EDT - 5 months ago

Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index

UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results

Aug 28, 2025, 6:09 PM EDT - 6 months ago

UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results

Carlsmed® Reports Second Quarter 2025 Financial Results

Aug 28, 2025, 4:01 PM EDT - 6 months ago

Carlsmed® Reports Second Quarter 2025 Financial Results

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025

Aug 14, 2025, 9:05 AM EDT - 6 months ago

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025

Carlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures

Aug 1, 2025, 9:05 AM EDT - 7 months ago

Carlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures

Carlsmed's aprevo® Powers First Personalized Cervical Spine Surgery

Jul 28, 2025, 9:05 AM EDT - 7 months ago

Carlsmed's aprevo® Powers First Personalized Cervical Spine Surgery

Carlsmed: Spine Play Does Not Have My Backing Yet

Jul 24, 2025, 4:14 AM EDT - 7 months ago

Carlsmed: Spine Play Does Not Have My Backing Yet

Carlsmed Announces Pricing of Initial Public Offering

Jul 22, 2025, 8:03 PM EDT - 7 months ago

Carlsmed Announces Pricing of Initial Public Offering

Carlsmed Announces Launch of Initial Public Offering

Jul 22, 2025, 7:20 PM EDT - 7 months ago

Carlsmed Announces Launch of Initial Public Offering

U.S. IPO Weekly Recap: Mining Companies Lead The Calendar As More Sizable IPOs Submit Initial Filings

Jul 19, 2025, 1:30 AM EDT - 7 months ago

U.S. IPO Weekly Recap: Mining Companies Lead The Calendar As More Sizable IPOs Submit Initial Filings

ARX AVBH KMRK LAWR MGRT MH NIQ

Carlsmed Files For IPO On High Growth And High Operating Losses

Jun 30, 2025, 11:00 AM EDT - 8 months ago

Carlsmed Files For IPO On High Growth And High Operating Losses

StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 10:23 PM
$CARL Q4 '25 Earnings Results & Recap Carlsmed anticipates gross margin to remain constant short-term and modestly increase medium-to-long-term due to efficiencies. The company also expects broader commercialization of its aprevo cervical platform in 2026.
0 · Reply
OnyxPredator
OnyxPredator Feb. 23 at 1:29 PM
$LFS $LONA $CARL $PAAS .’x
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 22 at 9:28 PM
$CARL Current Stock Price: $12.79
0 · Reply
SentimentSwings
SentimentSwings Feb. 18 at 3:36 PM
$CARL Carlyle Secured Lending is a BDC focused on first-lien loans. Yield is attractive but tied to credit health. NAV stability is the key performance metric.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 12 at 4:20 PM
$CARL RSI: 25.37, MACD: -0.4265 Vol: 0.76, MA20: 12.44, MA50: 12.90 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
RaymondNorman877
RaymondNorman877 Feb. 11 at 2:06 PM
$CARL Carl or unknown micro-cap; ticker ambiguous, likely represents a shell or dormant issuer with extreme liquidity constraints.
0 · Reply
jimbecker
jimbecker Jan. 27 at 5:29 PM
$CARL Regained the 50 Day Simple Moving Average on average volume. Sales increasing as well as institutional buying.
0 · Reply
Jesterberg69
Jesterberg69 Jan. 23 at 12:58 AM
$CARL CARL turns me on
0 · Reply
Yokozuna911
Yokozuna911 Jan. 22 at 3:49 PM
$CARL IPO stock lock-up period expired on Monday, January 19, 2026.
0 · Reply
Orveniuygv
Orveniuygv Jan. 13 at 6:38 PM
$CARL thin float microcap, quiet accumulation, watch for volume ignition and fast price discovery
0 · Reply
Cancel19
Cancel19 Dec. 18 at 2:58 PM
$CARL is this even trading today?
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 11:52 AM
BTIG updates rating for Carlsmed ( $CARL ) to Buy, target set at 24.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 11 at 2:39 PM
$CARL
0 · Reply
ZacksResearch
ZacksResearch Dec. 9 at 12:42 PM
$CARL drops 27.5% post-launch — what's behind the plunge? 📉 Despite the launch of its cervical fusion platform with strong clinical backing and favorable reimbursement, shares fell sharply. CARL's stock has declined 15.1% compared with the industry since its IPO. Understand the risks before investing in CARL 👉 https://www.zacks.com/stock/news/2801398/carl-launches-aprevo-cervical-platform-for-personalized-spine-surgery?cid=sm-stocktwits-2-2801398-body-23915&ADID=SYND_STOCKTWITS_TWEET_2_2801398_BODY_23915
0 · Reply
ZacksResearch
ZacksResearch Dec. 9 at 11:42 AM
$CARL just dropped a big catalyst in personalized spine surgery — and the momentum is real ⚡ The new aprevo cervical platform is out with early cases already underway, and CARL now has fresh reimbursement support pushing this launch forward. See what this move could mean for the growth story 👉 https://www.zacks.com/stock/news/2801398/carl-launches-aprevo-cervical-platform-for-personalized-spine-surgery?cid=sm-stocktwits-2-2801398-teaser-23914&ADID=SYND_STOCKTWITS_TWEET_2_2801398_TEASER_23914
0 · Reply
Jesterberg69
Jesterberg69 Nov. 28 at 4:42 PM
$CARL buy more CARL its good for the soul
0 · Reply
gianna_odn
gianna_odn Nov. 10 at 5:12 PM
$CARL Two concentrated days at GARPS 38 equals 48 hours of validation from GI KOLs 🔍 That feedback tightens logistics in 2025 and de risks endpoints headed into 2026 pivotal while the CRC TAM climbs with 1.9 million new cases
0 · Reply
Jesterberg69
Jesterberg69 Nov. 7 at 8:59 PM
$CARL I like this stock
0 · Reply
CH_Expat
CH_Expat Nov. 7 at 5:06 PM
$CARL Interesting. I always think Carlsberg though and this is a horrible bear like most of the beers that are not German or Czech.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 3:49 PM
Truist Securities updates rating for Carlsmed ( $CARL ) to Buy, target set at 18 → 20.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 9:29 AM
BTIG has adjusted their stance on Carlsmed ( $CARL ), setting the rating to Buy with a target price of 21 → 24.
0 · Reply